<![CDATA[Agenus Discontinues Phase 3 BATTMAN Trial in Metastatic MSS Colorectal Cancer]]>
Read the full article2d agoen
You might also wanna read
<![CDATA[Shifting the Paradigm: Evidence, Earlier Use, and Sequencing of BCMA-Targeted Therapies in Relapsed/Refractory Multiple Myeloma]]>
Pharmacy Times·10h ago
<![CDATA[Rationale and Timing: The Evolving Role of BCMA-Targeted Therapies in Relapsed/Refractory Multiple Myeloma ]]>
Pharmacy Times·7d ago
<![CDATA[Isatuximab Wins FDA Approval, Becoming Second Subcutaneous Anti-CD38 for Multiple Myeloma]]>
Pharmacy Times·6d ago
<![CDATA[FDA Grants Traditional Approval to Selpercatinib for RET Fusion-Positive Solid Tumors Across Multiple Cancer Types]]>
Pharmacy Times·2d ago
<![CDATA[Gedatolisib Combination Approved for PIK3CA Wild-Type HR+, HER2– Breast Cancer]]>
Pharmacy Times·2d ago
<![CDATA[Oncology PulsePoint: ASCO Updates Targeted Therapy for Stage IV NSCLC]]>
Pharmacy Times·3d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.